Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annie Yang

Showing results (41-50 of 87) with videos related to

Pageof 9
Sort By:
Molecular Therapy Oncolytics|November 2, 2023
Peritoneal-directed chimeric oncolytic virus CF17 prevents malignant ascites and improves survival in gastric cancer peritoneal metastasesAnnie Yang, Zhifang Zhang, Shyambabu Chaurasiya, et al.
Cancer Cell|April 20, 2005
Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 familyElsa R Flores, Shomit Sengupta, John B Miller, et al.
Journal for Immunotherapy of Cancer|April 5, 2023
Development of the oncolytic virus, CF33, and its derivatives for peritoneal-directed treatment of gastric cancer peritoneal metastasesAnnie Yang, Zhifang Zhang, Shyambabu Chaurasiya, et al.
Annals of Surgical Oncology|August 31, 2020
Impact of Neoadjuvant Therapy on Minimally Invasive Surgical Outcomes in Advanced Gastric Cancer: An International Propensity Score-Matched StudyYongjia Yan, Annie Yang, Li Lu, et al.
Journal of the American College of Surgeons|October 17, 2025
Oncolytic Properties of the Chimeric Poxvirus HOV-2 in Cholangiocarcinoma ModelsCourtney Chen, Jennifer Cillis, Sang-In Kim, et al.
Cancer Medicine|January 10, 2020
Assessment of variation in 30-day mortality following cancer surgeries among older adults across US hospitalsAllison Lipitz-Snyderman, Jessica A Lavery, Peter B Bach, et al.
Molecular Therapy Oncolytics|February 4, 2022
PET imaging and treatment of pancreatic cancer peritoneal carcinomatosis after subcutaneous intratumoral administration of a novel oncolytic virus, CF33-hNIS-antiPDL1Zhifang Zhang, Annie Yang, Shyambabu Chaurasiya, et al.
Cancers|December 9, 2023
Chimeric Antigen Receptor-T Cell and Oncolytic Viral Therapies for Gastric Cancer and Peritoneal Carcinomatosis of Gastric Origin: Path to Improving Combination StrategiesCourtney Chen, Audrey Jung, Annie Yang, et al.
Molecular Cancer Therapeutics|May 17, 2023
An oncolytic poxvirus encoding hNIS, shows anti-tumor efficacy and allows tumor imaging in a liver cancer modelShyambabu Chaurasiya, Hannah Valencia, Zhifang Zhang, et al.
The Breast Journal|September 16, 2021
Contralateral prophylactic mastectomy in the setting of breast cancer diagnosis and their insurance coverage in the United StatesMichael Ha, Ledibabari M Ngaage, Marissa Klein, et al.
Pageof 9

Showing results (41-50 of 87) with videos related to

Sort By:
Pageof 9
Molecular Therapy Oncolytics|November 2, 2023
Peritoneal-directed chimeric oncolytic virus CF17 prevents malignant ascites and improves survival in gastric cancer peritoneal metastasesAnnie Yang, Zhifang Zhang, Shyambabu Chaurasiya, et al.
Cancer Cell|April 20, 2005
Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 familyElsa R Flores, Shomit Sengupta, John B Miller, et al.
Journal for Immunotherapy of Cancer|April 5, 2023
Development of the oncolytic virus, CF33, and its derivatives for peritoneal-directed treatment of gastric cancer peritoneal metastasesAnnie Yang, Zhifang Zhang, Shyambabu Chaurasiya, et al.
Annals of Surgical Oncology|August 31, 2020
Impact of Neoadjuvant Therapy on Minimally Invasive Surgical Outcomes in Advanced Gastric Cancer: An International Propensity Score-Matched StudyYongjia Yan, Annie Yang, Li Lu, et al.
Journal of the American College of Surgeons|October 17, 2025
Oncolytic Properties of the Chimeric Poxvirus HOV-2 in Cholangiocarcinoma ModelsCourtney Chen, Jennifer Cillis, Sang-In Kim, et al.
Cancer Medicine|January 10, 2020
Assessment of variation in 30-day mortality following cancer surgeries among older adults across US hospitalsAllison Lipitz-Snyderman, Jessica A Lavery, Peter B Bach, et al.
Molecular Therapy Oncolytics|February 4, 2022
PET imaging and treatment of pancreatic cancer peritoneal carcinomatosis after subcutaneous intratumoral administration of a novel oncolytic virus, CF33-hNIS-antiPDL1Zhifang Zhang, Annie Yang, Shyambabu Chaurasiya, et al.
Cancers|December 9, 2023
Chimeric Antigen Receptor-T Cell and Oncolytic Viral Therapies for Gastric Cancer and Peritoneal Carcinomatosis of Gastric Origin: Path to Improving Combination StrategiesCourtney Chen, Audrey Jung, Annie Yang, et al.
Molecular Cancer Therapeutics|May 17, 2023
An oncolytic poxvirus encoding hNIS, shows anti-tumor efficacy and allows tumor imaging in a liver cancer modelShyambabu Chaurasiya, Hannah Valencia, Zhifang Zhang, et al.
The Breast Journal|September 16, 2021
Contralateral prophylactic mastectomy in the setting of breast cancer diagnosis and their insurance coverage in the United StatesMichael Ha, Ledibabari M Ngaage, Marissa Klein, et al.
Pageof 9